BioRestorative Therapies, Inc. Share Price
Equities
BRTX
US0906556065
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.37 USD | -4.20% | +0.37% | -21.26% |
Sales 2024 * | 60K 5.01M | Sales 2025 * | 60K 5.01M | Capitalization | 9.27M 774M |
---|---|---|---|---|---|
Net income 2024 * | -17M -1.42B | Net income 2025 * | -20M -1.67B | EV / Sales 2024 * | 155 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 155 x |
P/E ratio 2024 * |
-0.64
x | P/E ratio 2025 * |
-0.65
x | Employees | 11 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 81.2% |
1 day | -4.20% | ||
1 week | +0.37% | ||
Current month | -3.52% | ||
1 month | +4.18% | ||
3 months | +1.48% | ||
6 months | -27.51% | ||
Current year | -21.26% |
Managers | Title | Age | Since |
---|---|---|---|
Lance Alstodt
CEO | Chief Executive Officer | 53 | 01/18/01 |
Robert Kristal
DFI | Director of Finance/CFO | - | 04/21/04 |
Compliance Officer | 55 | 01/15/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Patrick Williams
BRD | Director/Board Member | 51 | 29/21/29 |
David Rosa
BRD | Director/Board Member | 59 | 29/21/29 |
Francisco Silva
CTO | Chief Tech/Sci/R&D Officer | 49 | 13/11/13 |
Date | Price | Change | Volume |
---|---|---|---|
10/24/10 | 1.37 | -4.20% | 58,204 |
09/24/09 | 1.43 | +0.70% | 35,453 |
08/24/08 | 1.42 | -3.40% | 323,780 |
07/24/07 | 1.47 | -0.68% | 130,716 |
06/24/06 | 1.48 | +8.42% | 167,005 |
Delayed Quote Nasdaq, May 11, 2024 at 01:30 am IST
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-21.26% | 9.27M | |
+3.91% | 109B | |
+10.87% | 105B | |
+1.28% | 22.25B | |
-13.14% | 22.09B | |
-7.05% | 18.68B | |
-38.36% | 17.58B | |
-10.66% | 16.85B | |
+3.75% | 13.76B | |
+36.70% | 12.46B |
- Stock Market
- Equities
- BRTX Stock